The SurgeryKEY test provides critical diagnostic insights for surgical site infections (SSIs) across various surgical disciplines, including general surgery. By detecting bacterial and fungal pathogens, it is particularly valuable in culture-negative infections, antibiotic-resistant organisms, and polymicrobial infections, which are often challenging to diagnose using conventional culture methods. This test is especially useful in cases where prior antibiotic use has suppressed microbial growth, making traditional culture-based diagnostics unreliable. 

Rapid sequencing using NGS technology, powered by advanced bioinformatics, enables broad microbial identification, detecting over 50,000 bacterial and fungal targets in a single sample. qPCR enables rapid detection of bacterial load and targeted pathogen identification, improving diagnostic sensitivity. The test also screens for 17 antibiotic resistance genes, supporting optimized antimicrobial therapy selection. 

Validated for intraoperative and postoperative swab, tissue, and fluid samples, SurgeryKEY includes a sample collection kit and delivers results within 3–5 days, providing clinicians with actionable data to guide surgical infection management and improve patient outcomes.